Pancreas Cancer Discussion Page:
An Unmoderated Forum *
|*DISCLAIMER: This page is an unmoderated forum, and the opinions expressed herein do not necessarily reflect the viewpoint of The Johns Hopkins Medical Institutions. Patients are advised to consult their personal physicians before making any medical decisions. |
Pancreas CancerFamilial pancreatic cancer was posted 08/13/2017 01:19 pm by Dr. Hruban
E-mail Address: email@example.com
In a recent paper in the Journal of Clinical Oncology (reference below), Dr.
Michael Goggins (the Sol Goldman Professor of Pancreatic Cancer Research at
Hopkins) and colleagues report that a fraction (~5%) of patients with
pancreatic cancer who don't have a family history of cancer, have an
inherited gene mutation that predisposed them to develop pancreatic cancer.
Goggins and colleagues sequenced 32 genes, including known pancreatic cancer
susceptibility genes, in DNA prepared from normal tissue obtained from 854
patients with pancreatic cancer.
They report that 33 (3.9%) of the 854
patients had inherited a cancer-causing gene mutation. These included
mutations in the known familial pancreatic cancer susceptibility genes:
BRCA2, ATM, BRCA1, PALB2, MLH1, CDKN2A, TP53, BUB1B and BUB3.
Recognizing these inherited mutations is important for two reasons. First,
other family members may also carry one of these mutations and they may
benefit from genetic counseling and cancer screening. Second, some of these
inherited mutations make the cancers particularly sensitive to certain
treatments. Cancers with inactivated BRCA1, BRCA2 or PALB2 may be more
sensitive to PARP inhibitors, and cancers with inactivated MLH1 may be more
sensitive to immunotherpay.
Congratulations Dr. Goggins and team!
J Clin Oncol. 2017 Aug 2:JCO2017723502. doi: 10.1200/JCO.2017.72.3502. [Epub
ahead of print]
Deleterious Germline Mutations in Patients With Apparently Sporadic
Shindo K1, Yu J1, Suenaga M1, Fesharakizadeh S1, Cho C1, Macgregor-Das A1,
Siddiqui A1, Witmer PD1, Tamura K1, Song TJ1, Navarro Almario JA1, Brant A1,
Borges M1, Ford M1, Barkley T1, He J1, Weiss MJ1, Wolfgang CL1, Roberts NJ1,
Hruban RH1, Klein AP1, Goggins M1.
Reply to this message |
Return to Main Message List
*DISCLAIMER: This page is an unmoderated forum, and the opinions expressed herein do not necessarily reflect the viewpoint of The Johns Hopkins Medical Institutions. Patients are advised to consult their personal physicians before making any medical decisions.
Pancreas Home |
Basic Sci |
Feedback | Pathology Home | Oncology Center Home | Search Copyright © 2020 The Johns Hopkins University, Baltimore, MarylandLast Modified: 11/11/2002 10:50 am